Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. UK BROKER RATINGS SUMMARY: Buy Dixons Carphone And AG Barr - Liberum

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Buy Dixons Carphone And AG Barr - Liberum

Mon, 04th May 2020 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

CITIGROUP CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 160 (165) PENCE - 'BUY'

----------

JPMORGAN CUTS RBS PRICE TARGET TO 180 (200) PENCE - 'OVERWEIGHT'

----------

UBS CUTS LLOYDS PRICE TARGET TO 45 (50) PENCE - 'BUY'

----------

CITIGROUP CUTS LLOYDS PRICE TARGET TO 42 (50) PENCE - 'BUY'

----------

BERENBERG RAISES LLOYDS PRICE TARGET TO 35 (34) PENCE - 'HOLD'

----------

CITIGROUP RAISES BARCLAYS PRICE TARGET TO 108 (106) PENCE - 'NEUTRAL'

----------

KEPLER CHEUVREUX RAISES RECKITT BENCKISER PRICE TARGET TO 7250 (6700) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES SEVERN TRENT PRICE TARGET TO 2250 (2160) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES J SAINSBURY PRICE TARGET TO 175 (170) PENCE - 'SELL'

----------

DEUTSCHE BANK CUTS INTERCONTINENTAL HOTELS TARGET TO 4300 (4600) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES ST JAMES'S PLACE PRICE TARGET TO 950 (930) PENCE - 'HOLD'

----------

BERENBERG RAISES POLYMETAL PRICE TARGET TO 1680 (1570) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES GLAXOSMITHKLINE PRICE TARGET TO 2060 (1900) PENCE - 'BUY'

----------

JPMORGAN CUTS AUTO TRADER GROUP PRICE TARGET TO 348 (368) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES UNILEVER PRICE TARGET TO 4300 (3850) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

LIBERUM RESUMES DIXONS CARPHONE WITH 'BUY' - PRICE TARGET 135 PENCE

----------

LIBERUM RAISES AG BARR TO 'BUY' ('HOLD') - PRICE TARGET 625 (580) PENCE

----------

BERENBERG RAISES INTEGRAFIN PRICE TARGET TO 500 (470) PENCE - 'BUY'

----------

JEFFERIES RAISES WEIR GROUP PRICE TARGET TO 1060 (1000) PENCE - 'HOLD'

----------

BARCLAYS CUTS 4IMPRINT GROUP PRICE TARGET TO 3300 (4800) PENCE - 'OVERWEIGHT'

----------

HSBC RAISES HILTON FOOD TO 'BUY' ('HOLD') - TARGET 1320 PENCE

----------

BERENBERG RAISES HOCHSCHILD MINING PRICE TARGET TO 190 (170) PENCE - 'HOLD'

----------

BERENBERG RAISES CENTAMIN PRICE TARGET TO 172 (148) PENCE - 'BUY'

----------

RBC CUTS MARKS & SPENCER PRICE TARGET TO 120 (125) PENCE - 'OUTPERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

MORGAN STANLEY CUTS ALLIED IRISH BANKS TARGET TO EUR1.50 (EUR3.25) - 'EQUAL-WEIGHT'

----------

LIBERUM RESUMES HOTEL CHOCOLAT WITH 'BUY' - TARGET 400 PENCE

----------

BERENBERG RAISES BREEDON PRICE TARGET TO 95 (85) PENCE - 'BUY'

----------

HSBC CUTS DART GROUP PRICE TARGET TO 880 (1710) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
67891011121314

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.